Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders

A Zhang, JL Neumeyer, RJ Baldessarini - Chemical reviews, 2007 - ACS Publications
Dopamine (DA) is a critical neurotransmitter in the mammalian central nervous system
(CNS). The cerebral dopaminergic system is implicated in the pathophysiology of several …

Structure-based discovery of opioid analgesics with reduced side effects

A Manglik, H Lin, DK Aryal, JD McCorvy, D Dengler… - Nature, 2016 - nature.com
Morphine is an alkaloid from the opium poppy used to treat pain. The potentially lethal side
effects of morphine and related opioids—which include fatal respiratory depression—are …

The proteasome as a potential target for novel anticancer drugs and chemosensitizers

KR Landis-Piwowar, V Milacic, D Chen, H Yang… - Drug resistance …, 2006 - Elsevier
A major challenge in cancer therapy is tumor drug resistance. To overcome it, it is essential
to understand the mechanisms and identify the molecules involved, so that they can be …

Copper-catalyzed yne-allylic substitutions using stabilized nucleophiles

S Niu, Y Luo, C Xu, J Liu, S Yang, X Fang - ACS Catalysis, 2022 - ACS Publications
Using stabilized “soft” nucleophiles in copper-catalyzed allylic substitutions is highly
desirable but remains an unsolved challenge for the last 40 years. In this work, a general …

Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists

L Bettinetti, K Schlotter, H Hübner… - Journal of medicinal …, 2002 - ACS Publications
Starting from dopamine receptor ligand BP897, an interactive drug discovery process
leading to heterocyclic bioisosteres is demonstrated. The four step strategy involved a …

Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level

A Tabor, S Weisenburger, A Banerjee, N Purkayastha… - Scientific reports, 2016 - nature.com
G protein–coupled receptors (GPCRs), including dopamine receptors, represent a group of
important pharmacological targets. An increased formation of dopamine receptor D2 …

Structure-guided development of heterodimer-selective GPCR ligands

H Hübner, T Schellhorn, M Gienger, C Schaab… - Nature …, 2016 - nature.com
Crystal structures of G protein-coupled receptor (GPCR) ligand complexes allow a rational
design of novel molecular probes and drugs. Here we report the structure-guided design …

Covalent agonists for studying G protein-coupled receptor activation

D Weichert, AC Kruse, A Manglik… - Proceedings of the …, 2014 - National Acad Sciences
Structural studies on G protein-coupled receptors (GPCRs) provide important insights into
the architecture and function of these important drug targets. However, the crystallization of …

Exploring Structural Determinants of Bias among D4 Subtype-Selective Dopamine Receptor Agonists

F Graßl, L Bock, A Huete-Huerta González… - Journal of Medicinal …, 2023 - ACS Publications
The high affinity dopamine D4 receptor ligand APH199 and derivatives thereof exhibit bias
toward the Gi signaling pathway over β-arrestin recruitment compared to quinpirole. Based …

Can agostic interaction affect regiochemistry of carbopalladation? Reverse regioselectivity in the palladium-catalyzed dimerization of aryl acetylenes

M Rubina, V Gevorgyan - Journal of the American Chemical …, 2001 - ACS Publications
Dimerization of terminal alkynes is a very practical and straightforward approach to
conjugated enynes-important building blocks for synthetic organic chemistry and key units …